MedTrace Logo

Phase 1 Study of ATRS-2002 in Healthy Male Adults

NCT04879589 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2023-04-28

No results posted yet for this study

Summary

To access the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered ATRA-2002 against commercially available oral formulation of abiraterone acetate in healthy male adults

Conditions

Interventions

DRUG

Abiraterone Acetate

ATRS-2002

Sponsors & Collaborators

  • Antares Pharma Inc.

    collaborator INDUSTRY

  • Syneos Health

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-04-20
Completion
2023-04-20

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04879589 on ClinicalTrials.gov